Indeed, NK cell activation is dependent on E7 epitope recognition, which is exclusively expressed in HPV16-infected tumor cells, and cytotoxicity is enhanced by the binding of CAR to the TROP2 target expressed mostly on tumor cells but also in some healthy tissues. Here, TACSTD2 is linked to neoplasm.